kresmion.
Pull a receipt

CytoDyn Inc. (CYDY)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.21
As of

Kresmion compiles this page from CYDY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

CytoDyn Inc. (CYDY): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-19.

As of . Source: SEC EDGAR filings for CYDY. Method and limitations.

COMPANY DOSSIER

See the full CYDY dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for CYDY on one page. Preview it with sample data, then open it live with a free account.

Preview the CYDY dossier

Active events for CYDY

  • mediumEarnings below estimates

    Q3-2021: Missed consensus by 17.6% - EPS $-0.06 vs $-0.051 estimate

    All 2026-06-22 events →
  • mediumEarnings below estimates

    Missed consensus by 17.6% - EPS $-0.06 vs $-0.051 estimate

    All 2026-06-12 events →

FREE, NO ACCOUNT

Every event on CYDY, as it fires

New filings, 13F moves and cross asset events on CYDY land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, CYDY

Related tickers

Follow CYDY on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CYDY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the CYDY dossier
Share

The CYDY intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.